In support of the biological significance of cancer-associated upregulated MEMO1 expression, were the observations that elevated MEMO1 levels correlated with a more aggressive disease prognosis and significantly reduced patient survival—in both breast [9] and colorectal cancer [37] cohorts. Here, MEMO1 is linked to cancer.